Fourth Quarter Highlights
Revenue up 5% underlying. 1% reported growth after -6% FX and 2% acquisition impacts
Established Markets revenue up 6%, our best quarterly performance since 2012
Emerging Markets revenue growth of 2% with strong growth in most markets offset by China
Sports Medicine Joint Repair revenue up 9%, driven by US and ArthroCare benefits
Another strong performance in Knee Implants with revenue up 6%
Advanced Wound Management businesses deliver 8% revenue growth, led by US performance
2015 Full Year Highlights
Full year underlying revenue growth of 4%, twice that achieved in 2014. Reported growth flat after -8% FX and 4% acquisition impacts
Trading profit margin up 80bps at 23.7%, reflecting Group Optimisation and ArthroCare synergies
$203m accounting charge (before future insurance recovery) taken for metal-on-metal claims
Proposed full year dividend distribution of 30.8¢ per share, up 4% year-on-year
